I welcome the U.S. Senate investigation into monopolistic drug manufacturers who commit unconscionable price gouging on GLP-1 medications. These global companies are reaping enormous profits that exponentially outweigh the costs to make them.
I welcome the U.S. Senate investigation into monopolistic drug manufacturers who commit unconscionable price gouging on GLP-1 medications. These global companies are reaping enormous profits that exponentially outweigh the costs to make them.